Not Signed In -
Prostate Cancer |
|
|
Prostate cancer is a disease in which cancer develops in the prostate, a gland in the male reproductive system. Cancer occurs when cells of the prostate mutate and begin to multiply out of control. These cells may spread (metastasize) from the prostate to other parts of the body, especially the bones and lymph nodes. Prostate cancer may cause pain, difficulty in urinating, erectile dysfunction and other symptoms. Rates of prostate cancer vary widely across the world. It is least common in S ...
Wikipedia - [full article]
Prostate Cancer Clinical Trials
- Diet and PSA Levels in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Positioning and Tracking the Prostate During External Beam Radiation
ClinicalTrials.gov Identifier: NCT00123838 - Active, not recruiting
Prostate Cancer; Cancer of Prostate; Neoplasms, Prostate
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005960 - Active, not recruiting
stage II prostate cancer; Pain; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003084 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00020995 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004928 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- A Study of Docetaxel Plus Carboplatin in Patients with Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00134706 - Active, not recruiting
Prostate Cancer; Cancer of the Prostate; Cancer of Prostate
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- PET Scan in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005947 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00084526 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002723 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003903 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; Osteoporosis
- Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00077402 - Active, not recruiting
recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030277 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003400 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- 17-AAG in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
ClinicalTrials.gov Identifier: NCT00118092 - Active, not recruiting
recurrent prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer
- Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00019695 - Active, not recruiting
Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
- Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082680 - Active, not recruiting
recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate
ClinicalTrials.gov Identifier: NCT00030290 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer
- Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
ClinicalTrials.gov Identifier: NCT00003858 - Active, not recruiting
stage III prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer; stage I prostate cancer
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Lycopene in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00068731 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003871 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
Prostate Cancer
- Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00054509 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
ClinicalTrials.gov Identifier: NCT00080899 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer
- Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003533 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003516 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00085228 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002760 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
- NCI HIGH PRIORITY CLINICAL TRIAL --- Prostatectomy Compared With Watchful Waiting in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002606 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
- CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
ClinicalTrials.gov Identifier: NCT00004026 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)
ClinicalTrials.gov Identifier: NCT00090363 - Active, not recruiting
Prostate Cancer
- Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00110162 - Recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002602 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002511 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003534 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00052845 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005992 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
ClinicalTrials.gov Identifier: NCT00078923 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028574 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer; Hot Flashes
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00043069 - Active, not recruiting
Osteoporosis; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00071968 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
- Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00039104 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
ClinicalTrials.gov Identifier: NCT00045123 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
ClinicalTrials.gov Identifier: NCT00005073 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer; Quality of Life
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
ClinicalTrials.gov Identifier: NCT00046826 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00024414 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003183 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006023 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Atrasentan in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00046943 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016107 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002703 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
- Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00122265 - Active, not recruiting
Prostate Cancer
- Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082693 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00003622 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
ClinicalTrials.gov Identifier: NCT00031746 - Active, not recruiting
Prostate Cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Clinical Trial for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
Prostate Cancer
- Cilengitide in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103337 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer
- Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00017563 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00022412 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
ClinicalTrials.gov Identifier: NCT00056407 - Active, not recruiting
Prostate Cancer
- Evaluate Risk Factors which Predict the Transformation of Early Stage to Clinically Aggressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00011349 - Active, not recruiting
Prostate Cancer
- Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00014352 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; Thromboembolism; recurrent prostate cancer
- Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00003391 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Brachytherapy in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005939 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
- Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Assessment of Primary Androgen Deprivation Therapy for Non-Metastatic Prostate Cancer Among Elderly
ClinicalTrials.gov Identifier: NCT00161252 - Recruiting
Prostate Cancer
- Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00054574 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Cilengitide in Treating Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00121238 - Recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
ClinicalTrials.gov Identifier: NCT00030901 - Active, not recruiting
Prostate Cancer
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00031889 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- 3-AP in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00054015 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer
- A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
ClinicalTrials.gov Identifier: NCT00087659 - Active, not recruiting
Prostate Cancer
- Selenium and Vitamin E in Preventing Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006392 - Active, not recruiting
Prostate Cancer
- MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00027781 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00027794 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
Resources
- Advancements in Treating Urological Disease (Cleveland Clinic)
- Agricultural Pesticide Use May Be Associated with Increased Risk of Prostate Cancer (National Cancer Institute)
email this page
print this page
bookmark this page
feedback on this page
